van Duikeren S - Search Results

1

Balancing between antitumor efficacy and autoimmune pathology in T-cell-mediated targeting of carcinoembryonic antigen.

Bos R, van Duikeren S, Morreau H, Franken K, Schumacher TN, Haanen JB, van der Burg SH, Melief CJ, Offringa R. Bos R, et al. Among authors: van duikeren s, van der burg sh. Cancer Res. 2008 Oct 15;68(20):8446-55. doi: 10.1158/0008-5472.CAN-08-1864. Cancer Res. 2008. PMID: 18922918

2

Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoire.

Bos R, van Duikeren S, van Hall T, Kaaijk P, Taubert R, Kyewski B, Klein L, Melief CJ, Offringa R. Bos R, et al. Among authors: van duikeren s, van hall t. Cancer Res. 2005 Jul 15;65(14):6443-9. doi: 10.1158/0008-5472.CAN-05-0666. Cancer Res. 2005. PMID: 16024649

3

Characterization of antigen-specific immune responses induced by canarypox virus vaccines.

Bos R, van Duikeren S, van Hall T, Lauwen MM, Parrington M, Berinstein NL, McNeil B, Melief CJ, Verbeek JS, van der Burg SH, Offringa R. Bos R, et al. Among authors: van duikeren s, van hall t, van der burg sh. J Immunol. 2007 Nov 1;179(9):6115-22. doi: 10.4049/jimmunol.179.9.6115. J Immunol. 2007. PMID: 17947686

4

Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer.

Speetjens FM, Lauwen MM, Franken KL, Janssen-van Rhijn CM, van Duikeren S, Bres SA, van de Velde CJ, Melief CJ, Kuppen PJ, van der Burg SH, Morreau H, Offringa R. Speetjens FM, et al. Among authors: van duikeren s, van der burg sh, van de velde cj. Int J Cancer. 2008 Aug 15;123(4):838-45. doi: 10.1002/ijc.23570. Int J Cancer. 2008. PMID: 18506693 Free article.

5

Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors.

van Duikeren S, Fransen MF, Redeker A, Wieles B, Platenburg G, Krebber WJ, Ossendorp F, Melief CJ, Arens R. van Duikeren S, et al. J Immunol. 2012 Oct 1;189(7):3397-403. doi: 10.4049/jimmunol.1201540. Epub 2012 Aug 22. J Immunol. 2012. PMID: 22914049

6

CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.

Rosalia RA, Cruz LJ, van Duikeren S, Tromp AT, Silva AL, Jiskoot W, de Gruijl T, Löwik C, Oostendorp J, van der Burg SH, Ossendorp F. Rosalia RA, et al. Among authors: van duikeren s, van der burg sh. Biomaterials. 2015 Feb;40:88-97. doi: 10.1016/j.biomaterials.2014.10.053. Epub 2014 Nov 26. Biomaterials. 2015. PMID: 25465442

7

Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell death.

van der Sluis TC, van Duikeren S, Huppelschoten S, Jordanova ES, Beyranvand Nejad E, Sloots A, Boon L, Smit VT, Welters MJ, Ossendorp F, van de Water B, Arens R, van der Burg SH, Melief CJ. van der Sluis TC, et al. Among authors: van duikeren s, van de water b, van der burg sh. Clin Cancer Res. 2015 Feb 15;21(4):781-94. doi: 10.1158/1078-0432.CCR-14-2142. Epub 2014 Dec 12. Clin Cancer Res. 2015. PMID: 25501579

8

Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression.

van der Sluis TC, Sluijter M, van Duikeren S, West BL, Melief CJ, Arens R, van der Burg SH, van Hall T. van der Sluis TC, et al. Among authors: van duikeren s, van hall t, van der burg sh. Cancer Immunol Res. 2015 Sep;3(9):1042-51. doi: 10.1158/2326-6066.CIR-15-0052. Epub 2015 Apr 17. Cancer Immunol Res. 2015. PMID: 25888578

9

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.

Welters MJ, van der Sluis TC, van Meir H, Loof NM, van Ham VJ, van Duikeren S, Santegoets SJ, Arens R, de Kam ML, Cohen AF, van Poelgeest MI, Kenter GG, Kroep JR, Burggraaf J, Melief CJ, van der Burg SH. Welters MJ, et al. Among authors: van duikeren s, van meir h, van der burg sh, van der sluis tc, van ham vj, van poelgeest mi. Sci Transl Med. 2016 Apr 13;8(334):334ra52. doi: 10.1126/scitranslmed.aad8307. Sci Transl Med. 2016. PMID: 27075626 Clinical Trial.

10

Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells.

Beyranvand Nejad E, van der Sluis TC, van Duikeren S, Yagita H, Janssen GM, van Veelen PA, Melief CJ, van der Burg SH, Arens R. Beyranvand Nejad E, et al. Among authors: van duikeren s, van veelen pa, van der burg sh, van der sluis tc. Cancer Res. 2016 Oct 15;76(20):6017-6029. doi: 10.1158/0008-5472.CAN-16-0881. Epub 2016 Aug 28. Cancer Res. 2016. PMID: 27569212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page